MedPath
HSA Approval

MAGNESIUM TRISILICATE COMPOUND TABLET BP

SIN06599P

MAGNESIUM TRISILICATE COMPOUND TABLET BP

MAGNESIUM TRISILICATE COMPOUND TABLET BP

October 1, 1991

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

MAGNESIUM TRISILICATE

250 mg

Magnesium trisilicate

ALUMINIUM HYDROXIDE GEL DRIED

120 mg

Aluminium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MAGNESIUM TRISILICATE COMPOUND TABLET BP - HSA Approval | MedPath